This is the eighth in a series of 6-Question interviews with the leaders who are challenging conventional thinking in Orthopedics (other interviews here).
I first heard of Trice Medical back in 2013. I was intrigued. Since their humble beginnings, they have completed the needed funding and clinical trials, upgraded the product and built a management team and sales force. Amazing! Trice has really started to make big disruptive waves in the diagnostics area. I recently listed Trice as a “Hot Startup to Watch”
I sat down with Jeff O’Donnell, CEO at Trice Medical to better understand their story.
1. How was Trice founded? Take us back to the start of the company and the inception of the idea.
Trice was founded in 2012. The goal was to perfect the in office diagnostic arthroscopy procedure. We asked the question: What if a patient could avoid an MRI and the multiple steps along the path towards recovery? Many patients present an obvious problem, where the doctor has a strong hunch about what is wrong. If the doctor could take a peek inside the joint at the first office visit the patient could avoid the costly MRI and the many steps towards recovery.
We took a 2.2mm needle and place...
